Release Date: 30/10/19 09:42 Summary: 4C Quarterly Cash Flow Report & Market Update Sept 2019 Price Sensitive: Yes Download Document 405.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%